MRI AutoDetect is currently available on BIOTRONIK’s newest line of CRM devices, including the Ilivia series for tachycardia. (Credit: PR Newswire)
The U.S. Food and Drug Administration (FDA) recently approved cardiac rhythm management (CRM) Devices with MRI AutoDetect Technology, developed by BIOTRONIK.
Patients with implantable heart devices (such as pacemakers), are usually unable to get an MRI performed due to malfunctions that can occur between the MRI and them implanted device.
However, this CRM device is able to sense when a patient is near an MRI environment and switch to “MRI mode”.
Click here to read the full release.
